Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
3.86M
-
Shares change
-
-94.6K
-
Total reported value, excl. options
-
$23.4M
-
Value change
-
-$574K
-
Number of sells
-
-3
-
Price
-
$6.07
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2023
3 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q4 2023.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.86M shares
of 316M outstanding shares and own 1.22% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21.5M shares), VANGUARD GROUP INC (13.6M shares), TPG GP A, LLC (12.3M shares), BlackRock Inc. (8.85M shares), Rubric Capital Management LP (8M shares), CITADEL ADVISORS LLC (6.5M shares), NEUBERGER BERMAN GROUP LLC (3.74M shares), DIMENSIONAL FUND ADVISORS LP (2.82M shares), STATE STREET CORP (2.8M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.44M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.